GlobalData on MSN
FDA clears Cepheid’s Xpert GI Panel for pathogen detection
The Xpert GI Panel identifies pathogens directly from stool specimens collected in Cary-Blair transport media.
The Danaher subsidiary aims to meet clinician needs for flexibility with a range of test size options for its vast installed base.
Cepheid announced today that it has received FDA clearance for Xpert GI Panel, a multiplex PCR test designed to provide fast and accurate detection of 11 clinically relevant gastrointestinal (GI) ...
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode announced that it has received U.S. Food and Drug Administration 510(k) clearance for BioCode Gastrointestinal Pathogen Panel (GPP) with high ...
SANTA FE SPRINGS, Calif.--(BUSINESS WIRE)--Applied BioCode announced today that it has received U.S. Food and Drug Administration 510(k) clearance for the use of the Roche MagNA Pure 96* Extraction ...
The US Food and Drug Administration (FDA) has cleared Hologic’s first gastrointestinal (GI) pathogen detection tests. The FDA clearance for the Panther Fusion GI Bacterial and Expanded Bacterial ...
Background. Molecular syndromic diagnostic panels can enhance pathogen identification in the approximately 2–4 billion episodes of acute gastroenteritis that occur annually worldwide. However, the ...
Following the first stay-at-home orders issued in the U.S. to curb the spread of COVID-19, gastrointestinal viruses such as norovirus, rotavirus and adenovirus all but disappeared from California ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results